Remdesivir Prices Cut On Government Intervention: Industry Body

Drug companies like Cadila Healthcare, Dr Reddy's Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of COVID-19.

To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday. Drug companies like Cadila Healthcare, Dr Reddy's Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of COVID-19. Union Chemicals and Fertilizers Minister Sadananda Gowda hailed the decision taken by the drug companies. In a tweet, he said: "In a huge relief to people in this crucial time, after govt''s intervention, the price of #Remdesivir is now reduced! I am grateful to pharma companies for standing along with PM @narendramodi's fight againt #Covid."